DMG-42. Development of a novel spinal cord diffuse midline glioma model unveils its immune microenvironment and potential therapeutic strategies
Reyes Hernández Osuna(Clinica Universidad de Navarra), Sara Labiano(Navarre Institute of Health Research), Timothy N. Phoenix(University of Cincinnati), M. Gómez Alonso(Clinica Universidad de Navarra), Daniel Palacios-Alonso(Clinica Universidad de Navarra), Jaime Gállego Pérez-Larraya(Clinica Universidad de Navarra), Sara Nuin(Clinica Universidad de Navarra), Jasper van der Lugt(Princess Máxima Center), Ana Patiño-García(Clinica Universidad de Navarra), Javier Marco-Sanz(Clinica Universidad de Navarra), Andrea Lacalle(Clinica Universidad de Navarra), Sandra Morales(Clinica Universidad de Navarra), Mariëtte E.G. Kranendonk(Princess Máxima Center)
Cited by 0
Related Papers
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells
|Proceedings of the National Academy of Sciences|2010|532
Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
|Clinical Cancer Research|2016|289
Human adipocyte extracellular vesicles in reciprocal signaling between adipocytes and macrophages
|Obesity|2013|232
Ultra-fast deep-learned CNS tumour classification during surgery
|Nature|2023|206